World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Tolentino YFM, Fogaça HS, Zaltman C, Ximenes LLL, Coelho HSM. Hepatitis B virus prevalence and transmission risk factors in inflammatory bowel disease patients at Clementino Fraga Filho university hospital. World J Gastroenterol 2008; 14(20): 3201-3206 [PMID: 18506926 DOI: 10.3748/wjg.14.3201]
URL:	https://www.wjgnet.com/1007-9327/full/v14/i20/3201.htm

(0) (0) (0) (4437) (35)

Number	Citing Articles
1	Lluís Castells. Vacuna contra el virus de la hepatitis B y enfermedad inflamatoria intestinal. Medicina Clínica 2009; 132(9) doi: 10.1016/j.medcli.2008.10.031
2	Mustafa Yakut, Gökhan Kabaçam, Yusuf Üstün, Hülya Cetinkaya, Irfan Soykan. Hepatitis B and C virus prevalence and related factors in patients with inflammatory bowel diseases. Clinics and Research in Hepatology and Gastroenterology 2011; 35(12) doi: 10.1016/j.clinre.2011.08.005
3	Hans Van Remoortel, Vere Borra, Emmy De Buck, Veerle Compernolle, Philippe Vandekerckhove. Is an endoscopic examination associated with transfusion‐transmissible infections? A systematic review and meta‐analysis. Transfusion 2018; 58(2) doi: 10.1111/trf.14416
4	Alfredo Papa, Carla Felice, Manuela Marzo, Gianluca Andrisani, Alessandro Armuzzi, Marcello Covino, Giammarco Mocci, Daniela Pugliese, Italo De Vitis, Antonio Gasbarrini, Gian Lodovico Rapaccini, Luisa Guidi. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. Journal of Crohn's and Colitis 2013; 7(2) doi: 10.1016/j.crohns.2012.03.001
5	Yash Hegde, Sarah K. Lazarus, Francis A. Farraye, Fauzia Hollnagel, Mary S. Hayney, Freddy Caldera. High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2025; 59(8) doi: 10.1097/MCG.0000000000002098
6	Nafiye Urganci, Derya Kalyoncu. Immunogenecity of Hepatitis A and B Vaccination in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 56(4) doi: 10.1097/MPG.0b013e31827dd87d
7	H. Abid, H. Meyiz, O. Laalaj, I. Mellouki, M. El Yousfi, N. Aqodad, D. Benajeh, A. Ibrahimi, M. El Abkari. Viral Hepatitis B during Chronic Inflammatory Bowel Diseases at Fez University Hospital: Prevalence and Risk Factors. Open Journal of Gastroenterology 2018; 8(01) doi: 10.4236/ojgas.2018.81002
8	Seong Jae Yeo, Hyun Seok Lee, Byung Ik Jang, Eun Soo Kim, Seong Woo Jeon, Sung Kook Kim, Kyeong Ok Kim, Yoo Jin Lee, Hyun Jik Lee, Kyung Sik Park, Yun Jin Jung, Eun Young Kim, Chang Heon Yang. Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease. Intestinal Research 2018; 16(3) doi: 10.5217/ir.2018.16.3.400
9	Jennifer L. Jones, Frances Tse, Matthew W. Carroll, Jennifer C. deBruyn, Shelly A. McNeil, Anne Pham-Huy, Cynthia H. Seow, Lisa L. Barrett, Talat Bessissow, Nicholas Carman, Gil Y. Melmed, Otto G. Vanderkooi, John K. Marshall, Eric I. Benchimol. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Gastroenterology 2021; 161(2) doi: 10.1053/j.gastro.2021.04.034
10	Luigi Marongiu, Jonathan J. M. Landry, Tobias Rausch, Mohammed L. Abba, Susanne Delecluse, Henri‐Jacques Delecluse, Heike Allgayer. Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors. Molecular Oncology 2021; 15(12) doi: 10.1002/1878-0261.13070
11	Jennifer L Jones, Frances Tse, Matthew W Carroll, Jennifer C deBruyn, Shelly A McNeil, Anne Pham-Huy, Cynthia H Seow, Lisa L Barrett, Talat Bessissow, Nicholas Carman, Gil Y Melmed, Otto G Vanderkooi, John K Marshall, Eric I Benchimol. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Journal of the Canadian Association of Gastroenterology 2021; 4(4) doi: 10.1093/jcag/gwab016
12	Luisa Guidi, Alfredo Papa, Daniela Pugliese, Carla Felice, Manuela Marzo, Alessandro Armuzzi, Gianluca Andrisani. What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(3): 387-396 doi: 10.4292/wjgpt.v7.i3.387 Abstract(2199) \| Core Tip(1472) \| Full Article(HTML)(5997) \| Full Article (PDF)-1062K(760) \| Full Article (Word)-270K(429) \| Audio-394K(28) \| Peer-Review Report-109K(339) \| Answering Reviewers-311K(326) \| Times Cited (4) \| Total Visits (8326) \| Open
13	Konstantinos H. Katsanos, Vasileios E. Tsianos, Christos D. Zois, Heleni Zioga, Ioannis Vagias, Eleftheria Zervou, Dimitrios K. Christodoulou, Epameinondas V. Tsianos. Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature. Journal of Crohn's and Colitis 2010; 4(4) doi: 10.1016/j.crohns.2010.03.001
14	J. P. Gisbert, M. Chaparro, M. Esteve. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2011; 33(6) doi: 10.1111/j.1365-2036.2010.04570.x
15	Elisabetta Degasperi, Flavio Caprioli, Omar El Sherif, David Back, Massimo Colombo, Alessio Aghemo. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection. Expert Review of Gastroenterology & Hepatology 2016; 10(12) doi: 10.1080/17474124.2016.1246181
16	Takashi Ishige, Toshiaki Shimizu, Kenji Watanabe, Katsuhiro Arai, Koichi Kamei, Takahiro Kudo, Reiko Kunisaki, Daisuke Tokuhara, Makoto Naganuma, Tatsuki Mizuochi, Atsuko Murashima, Yuta Inoki, Naomi Iwata, Itaru Iwama, Sachi Koinuma, Hirotaka Shimizu, Keisuke Jimbo, Yugo Takaki, Shohei Takahashi, Yuki Cho, Ryusuke Nambu, Daisuke Nishida, Shin-ichiro Hagiwara, Norikatsu Hikita, Hiroki Fujikawa, Kenji Hosoi, Shuhei Hosomi, Yohei Mikami, Jun Miyoshi, Ryusuke Yagi, Yoko Yokoyama, Tadakazu Hisamatsu. Expert consensus on vaccination in patients with inflammatory bowel disease in Japan. Journal of Gastroenterology 2023; 58(2) doi: 10.1007/s00535-022-01953-w
17	Jason K. Hou, Fernando Velayos, Norah Terrault, Uma Mahadevan. Viral hepatitis and inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(6) doi: 10.1002/ibd.21284
18	Sahin Coban, Murat Kekilli, Seyfettin Köklü. Approach and Management of Patients with Chronic Hepatitis B and C During the Course of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(11) doi: 10.1097/MIB.0000000000000126
19	Ece Mutlu, David Shapiro, Sohrab Mobarhan, Mark DeMeo, John Losurdo, Keith Bruninga, Rana Abraham, Michael Brown, Garth Swanson, Ali Keshavarzian, Sanjib Basu, Anuhya Gampa, Ruwaida Ben Musa. Hepatitis B vaccination in patients with inflammatory bowel disease. World Journal of Gastroenterology 2014; 20(41): 15358-15366 doi: 10.3748/wjg.v20.i41.15358 Abstract(1378) \| Core Tip(1325) \| Full Article(HTML)(4694) \| Full Article (PDF)-1080K(746) \| Full Article (Word)-375K(322) \| Peer-Review Report-165K(353) \| Answering Reviewers-357K(270) \| Times Cited (20) \| Total Visits (6756) \| Open
20	Khadija Chaudrey, Michelle Salvaggio, Aftab Ahmed, Sultan Mahmood, Tauseef Ali. Updates in vaccination: Recommendations for adult inflammatory bowel disease patients. World Journal of Gastroenterology 2015; 21(11): 3184-3196 doi: 10.3748/wjg.v21.i11.3184 Abstract(1520) \| Core Tip(1615) \| Full Article(HTML)(4852) \| Full Article (PDF)-971K(811) \| Full Article (Word)-288K(344) \| Peer-Review Report-125K(279) \| Answering Reviewers-251K(330) \| Times Cited (27) \| Total Visits (6628) \| Open
21	Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India. Intestinal Research 2017; 15(1) doi: 10.5217/ir.2017.15.1.97
22	Hai-yin Jiang, Shu-yin Wang, Min Deng, Yu-chuan Li, Zong-xin Ling, Li Shao, Bing Ruan. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis. Vaccine 2017; 35(20) doi: 10.1016/j.vaccine.2017.03.080
23	Georgios Axiaris, Evanthia Zampeli, Spyridon Michopoulos, Giorgos Bamias. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World Journal of Gastroenterology 2021; 27(25): 3762-3779 doi: 10.3748/wjg.v27.i25.3762 Abstract(1252) \| Core Tip(1170) \| Full Article(HTML)(4711) \| Full Article (PDF)-761K(645) \| Full Article (Word)-287K(368) \| Audio-898K(31) \| Peer-Review Report-220K(247) \| Answering Reviewers-410K(228) \| Times Cited (13) \| Total Visits (6939) \| Open
24	Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis. Cancers 2022; 14(20) doi: 10.3390/cancers14205085
25	Jennifer Coukos, Francis A. Farraye. Update on Vaccinating the Patient With Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2018; 16(4) doi: 10.1007/s11938-018-0200-4
26	Filomena Morisco, Fabiana Castiglione, Antonio Rispo, Tommaso Stroffolini, Roberto Vitale, Stefano Sansone, Rocco Granata, Ambrogio Orlando, Riccardo Marmo, Gabriele Riegler, Maurizio Vecchi, Livia Biancone, Nicola Caporaso. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease. Digestive and Liver Disease 2011; 43 doi: 10.1016/S1590-8658(10)60691-3
27	Cem Cekic, Fatih Aslan, Adnan Kirci, Zeynep Zehra Gümüs, Mahmut Arabul, Elif Sartas Yüksel, Sezgin Vatansever, Süreyya Gül Yurtsever, Emrah Alper, Belks Ünsal. Evaluation of Factors Associated With Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease. Medicine 2015; 94(22) doi: 10.1097/MD.0000000000000940
28	Isabella de Souza CUNHA, Tayná Cristina da SILVA, Éverson Fernando MALLUTA, Bruno Lorenzo SCOLARO, Pablo Sebastian VELHO, Juliane STALL. SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. Arquivos de Gastroenterologia 2020; 57(1) doi: 10.1590/s0004-2803.202000000-12
29	Dafan Chen, Shengzheng Luo, Qiwen Ben, Lungen Lu, Xinjian Wan, Jianjiong Wu. Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China. European Journal of Gastroenterology & Hepatology 2017; 29(5) doi: 10.1097/MEG.0000000000000838
30	Mei Lan Huang, Xi Tao Xu, Jun Shen, Yu Qi Qiao, Zhang Han Dai, Zhi Hua Ran. Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study. Journal of Crohn's and Colitis 2014; 8(4) doi: 10.1016/j.crohns.2013.08.017
31	Vincent P. Kuiper, Pauline van der Plas, Marie-Astrid Hoogerwerf, Jan Pieter R. Koopman, Andrea E. van der Meulen, Anna H.E. Roukens, Leo G. Visser, Meta Roestenberg. A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease. Vaccine 2022; 40(43) doi: 10.1016/j.vaccine.2022.09.006
32	N. Viget. Post’U FMC-HGE. 2009; doi: 10.1007/978-2-287-99247-6_9
33	Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. Intestinal Research 2023; 21(3) doi: 10.5217/ir.2022.00094
34	Renée M. Marchioni Beery, Joshua R. Korzenik. Treatment of Inflammatory Bowel Disease with Biologics. 2018; doi: 10.1007/978-3-319-60276-9_12
35	Amol Prabhakar Patil, Ebby George Simon, Amit Kumar Dutta, Anjilivelil Joseph Joseph, Reuben Thomas Kurien, Sudipta Dhar Chowdhury. Prevalence of serological markers of hepatitis B in inflammatory bowel disease – Experience from a tertiary care centre in South India. Tropical Doctor 2021; 51(3) doi: 10.1177/00494755211015571